ImageBiopsy Lab
ImageBiopsy Lab builds AI software for musculoskeletal imaging: it reads X-rays and CT scans for radiologists and orthopedists, then returns standardized quantitative measurements and structured reports directly inside the hospital's existing PACS and RIS workflow.
What is ImageBiopsy Lab?
ImageBiopsy Lab is the commercial brand of IB Lab GmbH, an Austrian publisher headquartered at Zehetnergasse 6/2/2 in Vienna, with a sister company, ImageBiopsy Lab, Inc., in New Jersey. It specializes in AI-assisted analysis of musculoskeletal (MSK) imaging and states its positioning as Redefining Bone Health: AI for Screening, Diagnostics and Surgery, with a declared mission to improve the quality of life of more than a billion MSK patients.
It answers the manual, operator-dependent nature of MSK measurement on radiographs and CT with a portfolio of narrow, anatomy-specific modules gathered under IB Lab ZOO, a modular MSK software platform. IB Lab KOALA™, the Knee Osteoarthritis Labeling Assistant, grades knee osteoarthritis against OARSI and Kellgren & Lawrence criteria. IB Lab LAMA™, the Leg Geometry Measurement Assistant, returns twelve standardized pre- and post-operative lower-limb measurements and supports hip and knee arthroplasty. HIPPO measures hip angles and pelvic morphology, including CCD and LCE angles; PANDA estimates bone age using Greulich & Pyle to follow a child's growth; SQUIRREL covers scoliosis with Cobb angle, pelvic tilt, Risser score, triradiate cartilage and vertebral numbering; FLAMINGO screens for vertebral fractures on spine CT; FROG analyzes foot geometry through deep learning. Two further products are distributed rather than developed in-house: RBfracture™, which detects fractures on appendicular skeleton radiographs, and Rho® by 16 Bit, which screens for low bone mineral density and returns a score from 1 to 10 correlated with the DXA-derived T-score. A further module, GECKO, appears only in a contact form drop-down, with no product page.
Integration is the selling point: imaging flows to IB Lab and results come back into the PACS/RIS as an image report and a text report, so the clinician does not change tool. The publisher claims more than 100 installations in 10+ countries, displays CE and FDA badges product by product, and lists over forty external scientific publications. A June 2026 partnership with PACS specialist aycan Digitalsysteme GmbH, of the PARATUS group, pushes the analysis further into radiology and orthopedic environments, and UCB has licensed its BoneBot osteoporosis technology to ImageBiopsy Lab. Leadership is named publicly: Reinhard Krickl (CEO), Richard Ljuhar (founder, Chief Innovation & Chief Commercial Officer), Christoph Götz (co-founder, COO), Zsolt Bertalan (CTO) and Günter K. Angel (CFO). The main reservation is transparency: no pricing is published anywhere, no full incorporation date is given, and the ZOO platform's product page renders empty.
What it does
- Analyze musculoskeletal radiographs and CT examinations automatically
- Produce standardized quantitative measurements: angles, indices and scores
- Return a report into the existing PACS/RIS, as an image report and a text report
- Screen opportunistically for low bone density or vertebral fractures on examinations acquired for another reason
- Follow change over time when prior examinations are available
When to use ImageBiopsy Lab / When not to
A quick filter to help you decide if ImageBiopsy Lab is the right fit.
When to use ImageBiopsy Lab
- Radiology departments that already run a PACS/RIS and want automated musculoskeletal measurements delivered inside their existing reading workflow
- Hospitals and clinics looking for reproducible, standardized MSK measurements: knee osteoarthritis grading, hip angles, leg geometry, bone age, scoliosis and vertebral fractures
- Teams running opportunistic osteoporosis screening on examinations already acquired for another reason
- Emergency and trauma units that want automated fracture detection support on appendicular skeleton radiographs
- Research organizations and pharmaceutical companies working on musculoskeletal diseases, whom the publisher names among its main customers alongside physicians
When not to use ImageBiopsy Lab
- Individual consumers and patients: this is a medical device sold to institutions under a Sales Agreement, with no online purchase
- Buyers who need to compare budgets before talking to anyone: no price, no rate card and no pricing model are published
- Teams looking for neurological, thoracic or cardiac imaging AI: the scope is strictly musculoskeletal, bones and joints
- Organizations planning to resell, sublicense, lease or operate the software as a service bureau, on a time-sharing basis or for commercial training, all of which the EULA prohibits
- Anyone under 18, the minimum age the privacy policy sets for using the website
How to use ImageBiopsy Lab
A typical end-to-end flow, from setup to results.
- Start from any page of the site and open the 'Get Demo' or 'Book a Demo' form: there is no self-service sign-up
- Choose the free demo you want to evaluate; the publisher announces unlocking within 24 hours
- Log in to the free trial portal at demo.imagebiopsy.com and upload your own test images
- Compare the results returned by the module against your own reading
- Discuss scope and terms with the sales team, since commercial conditions are set in a Sales Agreement rather than published online
- Have the product installed: the EULA states that product installation is completely remote
- Connect the modules to the existing PACS/RIS so that studies reach the analysis automatically
- Let the relevant algorithm trigger on the incoming examination: IB Lab SQUIRREL, for instance, is triggered automatically by a scoliosis study
- Read the PACS image report and the text report returned alongside the original examination
- Reach support at support@imagebiopsy.com, through support.imagebiopsy.com, or on the direct line +43 1 9051206 3000, Monday to Friday 09:00-14:00
Pros & Cons
Pros
- Broad and genuinely specialized MSK portfolio: ten named modules covering six anatomical regions, gathered under the ZOO platform
- Unusually substantial published evidence base, with more than forty external scientific references listed on the evidence page
- Regulatory markings displayed product by product, with distinct CE and FDA variants for KOALA™ and LAMA™
- Announced integration into the existing PACS/RIS, so the clinician keeps their reading environment
- A real free trial: test images can be uploaded to the publisher's portal, with unlocking announced within 24 hours
- Named clinician testimonials rather than anonymous quotes: Jack Farr MD, Jochen Mueller-Stromberg MD, Michael Gruber MD and Prof. Jochen Hofstätter, MD
- Commercial presence on both sides of the Atlantic, in Vienna and New Jersey, plus a distribution partnership with established PACS publisher aycan Digitalsysteme GmbH
Cons
- No public pricing at all: no pricing page, no amount and no published pricing model, everything goes through a sales contact
- No API: no API documentation exists and the site never mentions one
- No data retention period is published, neither in the privacy policy, nor in the terms, nor in the EULA
- No Data Processing Agreement is published or announced as available, and there is no formal list of sub-processors
- No security certification is displayed: no ISO 13485, no ISO 27001, no SOC 2 and no named notified body
- Nothing is said about where customer data is hosted, and the publisher's position on training its models on customer data is undocumented
- Several gaps on the company's own pages: the ZOO product page is empty, with 'No items found.' in the Problems, Solutions, Product description and Intended use blocks; no full incorporation date is published; and the support portal shows nothing without authentication
Pricing & Plans
No price is published anywhere on this site. There is no pricing page: /pricing and /plans both return a 404, no such page appears in the sitemap, and the word pricing is absent from every page collected. The tool is sold under contract, the EULA referring payment terms to one or more Sales Agreement forms and mentioning license fees, product maintenance coverage and usage Contracted Limits without ever stating an amount. The percentages that do appear in the EULA are contractual penalties for exceeding usage limits, for late payment and for denied access, not tariffs. A free trial portal does exist, with test-image upload and unlocking announced within 24 hours, but it is a trial and not a permanent free plan. No currency is established either. Any figure has to be obtained through the demo request and the sales team.
Data, GDPR & hosting
A consolidated view of how ImageBiopsy Lab handles your data.
GDPR overview
GDPR implementation is stated but thin. The privacy policy declares that data is processed solely on the basis of the statutory provisions, naming GDPR 2018 and the Austrian TKG 2003. The controller is IB Lab GmbH, Zehetnergasse 6/2/2, 1140 Vienna, Austria. The policy sets out the rights of information, correction, deletion, restriction, data portability, revocation and opposition, and gives mail@imagebiopsy.com as the channel to exercise them. The supervisory authority named is the Austrian Datenschutzbehörde (dsb.gv.at). IP anonymization is enabled on Google Analytics. No Data Protection Officer is named, and no Article 27 representative is designated, the publisher being established inside the EU. No retention period is published and no formal list of processors exists.
Who owns the data?
The product EULA is explicit on ownership: the ownership of the data placed on IB Lab servers lies with the Customer. IB Lab claims no right over the clinical images or the results a customer sends for analysis. Both parties acknowledge their own responsibility for complying with security and data protection law, and the customer remains accountable for its own technical, organizational and procedural controls. The privacy policy separately describes the processing of radiology scan images uploaded to the free trial portal, for the sole purpose of analyzing them and returning the results. No Data Processing Agreement is published or referenced, neither on the site nor in the thirty-page EULA.
Reuse rights
Because the customer keeps ownership of the data it places on IB Lab servers, it can reuse its own images and results without asking the publisher for permission; the EULA sets no restriction on that side. What the EULA does restrict is the software itself, which may not be sold, sublicensed, leased or used for commercial or collaboration purposes such as training, time-sharing, bureau-based licensing or cooperative sharing. On the website side, the privacy policy lists the personal data collected: form data (name, email, profession, country, message content), technical visit data (referring URL, browser, IP address), third-party data used to complete and validate the database under Article 14 and the legitimate interest basis of Article 6(1)(f) GDPR, and sensitive health data from free trial portal users, namely radiology scan images, processed to analyze the images and provide the results of the analysis. Stated purposes are website access, answering enquiries, delivering the services, running the free trial, the newsletter, technical diagnostics, audience measurement and legal obligations. Data may be disclosed to affiliated and sister companies, form providers, marketing teams under a legal basis, and public authorities; service providers are contractually bound not to share visitor data with anyone else. Named third-party trackers are Google Analytics with IP anonymization, Google Fonts, Google Maps, YouTube, Facebook social plugins and the Facebook pixel. Nowhere on the site or in the EULA does the publisher state whether customer data is used to train its models: the word training, in the EULA, refers to clinical training of users, not to model training.
Data retention & training
Hosting summary
No hosting country and no hosting region are published. The site never states where customer data or imaging is stored. The EULA refers to IB Lab servers without locating them, and specifies that product installation is completely remote. The publisher is established in Austria and its privacy policy is governed by the GDPR and the Austrian TKG, which tells you the law applicable to the website's processing but says nothing about the physical or contractual location of the imaging infrastructure; the two should not be conflated, and the publisher's country must not be read as a hosting country. The only location-related statement in the policy concerns website analytics, not clinical data: Google Analytics IP anonymization shortens the IP address within the EU/EEA, the full address being transmitted to a Google server in the United States only in exceptional cases. That applies to audience measurement on the website, not to customer imaging. Any data residency requirement therefore has to be answered contractually, because it cannot be established from the published material.
Things to keep in mind
Risks and trade-offs to weigh before adopting ImageBiopsy Lab.
- This is a medical device: regulatory status differs by product and by market, so check that the module you intend to use is authorized in your country before any clinical use
- The EULA states that a product or feature may only be used once the vendor formally announces that it has been released and is available as a certified medical device
- No public price means no budget can be estimated without going through the sales team
- Automation invites over-reliance: these measurements are decision support, and a reader who stops verifying them risks eroding the very skill the tool is meant to accelerate
- Neither the hosting location nor the retention period is documented, and the publisher's position on training its models on customer data is not stated either: three questions to settle contractually before sending any patient imaging
- The ZOO platform's product page is empty of content, so the platform's own scope has to be established with the publisher rather than read from the site
- The general terms point to sector-wide FEEI model contracts, from the Austrian federation of electrical and electronics industries, rather than to a contract drafted by the publisher; only the EULA is specific to the product
Setup & Integrations
Technical difficulty
Low effort on the customer side, but not a self-service install. The EULA states that product installation is completely remote, so the publisher carries the deployment. What the institution has to supply is a PACS/RIS environment for the modules to slot into, plus the internal coordination any imaging integration requires. Professional Services in the EULA include clinical training for super-users, technicians and end users. The aycan partnership is presented as shortening access to the AI without a change of system. For evaluation alone, the free trial unlocks within 24 hours and needs nothing more than test images.
Deployment
Integrations
Behind ImageBiopsy Lab
Social
Resources
All the official URLs gathered for verification and reference.
Frequently asked questions
What does ImageBiopsy Lab actually do?
Who publishes the software?
Which products are in the portfolio?
How does it fit into an existing radiology workflow?
How much does it cost?
Is there a free trial?
Is there an API?
Are the products CE marked or FDA cleared?
How do I exercise my GDPR rights?
What support is available?
Should you pick ImageBiopsy Lab?
ImageBiopsy Lab is a focused player rather than a generalist. IB Lab GmbH has built its entire catalogue around one clinical territory, musculoskeletal imaging, and covers it with ten named modules spanning knee, hip, leg, hand, foot and spine, gathered under the ZOO platform. Two of those products, RBfracture™ and Rho® by 16 Bit, come from third parties and are distributed rather than developed in Vienna, a distinction worth keeping in mind when judging what the company itself has built.
On the credibility side, the evidence stands out: more than forty external scientific references are listed publicly, regulatory markings are shown product by product, and two modules carry separate CE and FDA variants. The integration story is coherent too, since results return into the PACS/RIS as an image report and a text report and the radiologist keeps their reading environment. The free trial is real: you upload your own test images and compare, with unlocking announced within 24 hours.
The weakness is transparency of a different kind, commercial and legal. There is no published price, no pricing model, no retention period, no Data Processing Agreement, no formal sub-processor list, no security certification and no statement of where customer data is hosted or whether it is used to train models. For a medical device sold to hospitals, several of those questions will surface during procurement anyway, but none of them can be answered from the website.
The realistic path is therefore to request a demo, run your own images through the trial portal, and then negotiate a contract. Buyers who need to compare budgets before speaking to a salesperson, or who want a documented data governance posture up front, will have to ask for it directly.
- Choosing a selection results in a full page refresh.
- Opens in a new window.